Consistent with these findings, activating the Jag2/Notch1/Hes5 signaling axis by interfering with SVEP1/integrin α9β1 binding significantly increased the proliferation, migration, and invasion of ICC cells. The gene discussed is HES5; the disease is intrahepatic cholangiocarcinoma.